Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Jörgen, Syk"'
Autor:
Johanna Karlsson Sundbaum, Jon R. Konradsen, Lowie E.G.W. Vanfleteren, Sten Axelsson Fisk, Christophe Pedroletti, Yvonne Sjöö, Jörgen Syk, Therese Sterner, Anne Lindberg, Alf Tunsäter, Fredrik Nyberg, Ann Ekberg-Jansson, Caroline Stridsman
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 16 (2022)
Background: Severe asthma increases the risk of severe COVID-19 outcomes such as hospitalization and death. However, more studies are needed to understand the association between asthma and severe COVID-19. Methods: A cohort of 150,430 adult asthma p
Externí odkaz:
https://doaj.org/article/d9c353a2ea374dffac241098c6f69724
Autor:
Ines Vinge, Jörgen Syk, Athanasios Xanthopoulos, Hendrik Laßmann, Mikko Vahteristo, Ulla Sairanen, Satu Lähelmä, Rudolf Hennig, Matthias Müller
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Background: Selection of the most appropriate device for a switch from one inhaler to an equivalent product is known to have a major impact on clinical outcomes in patients with asthma or chronic obstructive pulmonary disease (COPD). Salmeterol/fluti
Externí odkaz:
https://doaj.org/article/4549a50f14a9481c9594b55bf1fed9e0
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197795 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0185019.].
Externí odkaz:
https://doaj.org/article/2c5067f0506b421ea33b7337995e4fee
Autor:
Lilla Tamási, Mária Szilasi, Jörgen Syk, Athanasios Xanthopoulos, Tari Haahtela, Paula Rytilä, Federico Lavorini, Anna S. Pelkonen, Abel Pallarés-Sanmartin, Jerzy Chudek, Gabriella Gálffy
Publikováno v:
Pulmonary Therapy. 7:409-427
Asthma and chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality worldwide. Optimal control of these conditions is a constant challenge for both physicians and patients. Poor inhaler practice is widespread and is a
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185019 (2017)
Asthma is a chronic inflammatory respiratory disorder associated with reduced lung function and poor quality of life. The condition is also associated with poor self-rated health, a major predictor of objective health trajectories. Of biological corr
Externí odkaz:
https://doaj.org/article/9e8a59c36e554878b5aeb6c9463feaff
Autor:
Caroline Stridsman, Ann Jansson, Johanna Karlsson Sundbaum, Jon R Konradsen, Alf Tunsäter, Lowie E.G.W. Vanfleteren, Anne Lindberg, Sten Axelsson Fisk, Yvonne Sjöö, Jörgen Syk, Fredrik Nyberg, Christophe Pedroletti
Publikováno v:
Epidemiology.
Autor:
Caroline Stridsman, Ann Jansson, Yvonne Sjöö, Christophe Pedroletti, Fredrik Nyberg, Johanna Karlsson Sundbaum, Lowie E.G.W. Vanfleteren, Sten Axelsson Fisk, Anne Lindberg, Jörgen Syk, Jon R Konradsen, Alf Tunsäter
Publikováno v:
Epidemiology.
Autor:
Matthias Müller, Hendrik Laßmann, Satu Lähelmä, Ines Vinge, Jörgen Syk, Rudolf Hennig, Ulla Sairanen, Mikko Vahteristo, Athanasios Xanthopoulos
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Background: Selection of the most appropriate device for a switch from one inhaler to an equivalent product is known to have a major impact on clinical outcomes in patients with asthma or chronic obstructive pulmonary disease (COPD). Salmeterol/fluti
Autor:
Federico, Lavorini, Jerzy, Chudek, Gabriella, Gálffy, Abel, Pallarés-Sanmartin, Anna S, Pelkonen, Paula, Rytilä, Jörgen, Syk, Maria, Szilasi, Lilla, Tamási, Athanasios, Xanthopoulos, Tari, Haahtela
Publikováno v:
Pulmonary Therapy
Asthma and chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality worldwide. Optimal control of these conditions is a constant challenge for both physicians and patients. Poor inhaler practice is widespread and is a
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Josep Darbà,1 Meritxell Ascanio,2 Jörgen Syk,3– 5 Kjell Alving4 1Department of Economics, Universitat de Barcelona, Barcelona, Spain; 2BCN Health Economics & Outcomes Research, S.L., Barcelona, Spain; 3Department of Neurobiology, Care Sciences an